Zobrazeno 1 - 10
of 232
pro vyhledávání: '"J. A. Chayvialle"'
Autor:
Valérie Hervieu, J. Forestier, J-A Chayvialle, Y. Molin, Thomas Walter, B van Brakel, J.Y. Scoazec, Cécile Vercherat, M-O Joly, C. Lombard-Bohas
Publikováno v:
British Journal of Cancer
Background: O6-Methylguanine-DNA methyltransferase (MGMT) loss of expression has been suggested to be predictive of response to temozolomide in neuroendocrine tumours (NETs), but so far, only limited data are available. We evaluated the prognostic an
Publikováno v:
La Revue de Médecine Interne. 32:600-604
Resume Propos Plusieurs cas de thrombose ont ete decrits dans la maladie cœliaque. Dans ce travail, nous avons analyse les caracteristiques cliniques et les facteurs de thrombophilie de sept patients adultes ayant presente une thrombose associee a u
Autor:
A. Bado, J.-A. Chayvialle
Publikováno v:
EMC - Gastro-entérologie. 6:1-14
Autor:
Jean-Yves Scoazec, M. Labadie, Thierry Ponchon, B. Napoléon, P. E. Queneau, Bertrand Pujol, J. C. Souquet, Christine Lefort, R. Gincoul, J. A. Chayvialle, Vincent Lepilliez, M. V. Alvarez-Sanchetz
Publikováno v:
Endoskopie heute. 23:213-220
BACKGROUND AND STUDY AIMS: Distinguishing pancreatic adenocarcinoma from other pancreatic masses remains challenging with current imaging techniques. This prospective study aimed to evaluate the accuracy of a new procedure, imaging the microcirculati
Autor:
J. A. Chayvialle, C. Lombard-Bohas
Publikováno v:
Oncomagazine. 2:12-21
Autor:
F Toscano, Z El Fajoui, F Gay, N Lalaoui, B Parmentier, J-A Chayvialle, J-Y Scoazec, O Micheau, J Abello, J-C Saurin
Publikováno v:
Oncogene. 27:4161-4171
Oxaliplatin has emerged as a major chemotherapeutic drug in the treatment of advanced colorectal cancer, yet like most conventional cancer therapeutics, its efficacy is often compromised due to p53 mutations. Unlike oxaliplatin, tumour necrosis facto
Autor:
Guillaume Cadiot, M. Eoche, H. Salloum, J. A. Chayvialle, E. Poncin, Georgia Malamut, Vered Abitbol, Lysiane Marthey, J. Lacroute, Philippe Pouderoux, R. Bobichon, P. Colardelle, Philippe Seksik, Guillaume Savoye, Nadine Cerf-Bensussan, Franck Carbonnel, Bertrand Meresse, F. Zerbib, Pauline Wils, S. Peschard, B. Mesnard, Anne Druez, M. Gompel, D. Parlier, F. Skinazi
Publikováno v:
Alimentary Pharmacology and Therapeutics
Alimentary Pharmacology and Therapeutics, 2014, 40 (9), pp.1103-1109. ⟨10.1111/apt.12937⟩
Alimentary Pharmacology and Therapeutics, Wiley, 2014, 40 (9), pp.1103-1109. ⟨10.1111/apt.12937⟩
Alimentary Pharmacology and Therapeutics, 2014, 40 (9), pp.1103-1109. ⟨10.1111/apt.12937⟩
Alimentary Pharmacology and Therapeutics, Wiley, 2014, 40 (9), pp.1103-1109. ⟨10.1111/apt.12937⟩
International audience; BACKGROUND: Recently, a new enteropathy has been described: olmesartan-associated enteropathy. However, the association has been questioned: a phase 3 trial and a cohort study found no association between gastrointestinal even
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19dc38feb2c60a10f1618950b3d18089
https://hal.science/hal-01064606
https://hal.science/hal-01064606
Publikováno v:
Biochemical and Biophysical Research Communications
Biochemical and Biophysical Research Communications, Elsevier, 1994, 200 (3), pp.1382-1390
Biochemical and Biophysical Research Communications, Elsevier, 1994, 200 (3), pp.1382-1390
The cellular events associated with cAMP-dependent cholecystokinin (CCK) release were investigated with an X-ray induced rat pancreatic tumor cell line (RIN 1056 E). Forskolin dose-dependently stimulated the release of CCK. Agents that increase [Ca2+
Publikováno v:
La Revue de medecine interne. 32(10)
Thrombotic events may occur in celiac disease. In this study, we analyzed clinical features and risk factors for thrombosis in seven patients who had celiac disease and thrombosis.We retrospectively studied 87 patients with adult celiac disease and i